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Abstract
Leptomycin B (LMB) was originally discovered as a potent anti-fungal antibiotic from Streptomyces species. 
The cellular target of LMB has been identifi ed as the nuclear export receptor CRM-1 or exportin-1, which is 
involved in nuclear traffi cking of cellular RNAs or proteins containing the nuclear export sequence (NES). 
CRM-1 is the main mediator of nuclear export in many cell types including hepatocyte cell lines. The ability 
of LMB to inhibit nuclear export has made it a useful tool in the study of the intracellular localization of many 
regulatory proteins. In this study, we evaluated the effect of nuclear export inhibitor LMB treatment on the 
intracellular localization of HBV core protein  into the hepatocyte cell lines, Huh-7 and HepG2 cells. We also 
reported the quantifi cation of the distribution of EGFP-Core fusion protein with redundant core NLS as well 
as SV-40 NLS into cell compartments.  Results shown that in Huh-7 cells treatment of LMB caused retention of 
EGFP-Core fusion protein into the nucleus, so increased the nuclear localization of EGFP-Core and all variants. 
In HepG2 cells, although not signifi cantly, treatment of LMB increased a number of nuclear localization in all 
EGFP-Core constructions, even the nuclear localization in HepG2 cells is not so high as in Huh-7 cells.
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Introduction
Hepatitis B virus (HBV) is a major human 
pathogen causing acute and chronic hepatitis 
or liver infl ammation. HBV is the prototype 
of a family of hepatotrophic, enveloped 
DNA viruses with a very narrow host range, 
referred to as hepadnaviridae. Virus particle is 
spheric which has a diameter of 42 nm and 
consists of an envelope carrying three surface 
proteins. It surrounds an icosahedral capsid 
enclosing an open circular with partially 
double stranded DNA (3.2-kb) as well as 
the viral DNA polymerase. HBV capsid 
has a diameter of 30 nm and is formed by 
multiple copies of one species of core protein 
(Nassal, 1996). HBV capsid is known as HBV 
core protein consists of 185 amino acids (aa) 
for genotype A and forms dimers which 
self-assemble in heterologous expression 
systems into shells of T=3 and T=4 symmetry 
(Zlotnick et al., 1996). The C-terminal of HBV 
core protein which consist of 30 aa are very 
rich in arginine residues and probably bind 
to the encapsidated viral nucleic acid. The 
N-terminal 155 aa are suffi cient for capsid 
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formation and referred to as the assembly 
domain (Gallina et al., 1989).
During infection the nucleocapsid of HBV 
is released from the incoming virus into the 
cytoplasm. Then the viral DNA genome is 
transported into the nucleus and repaired to 
give a circular covalently closed DNA (cccDNA), 
called as episome. The cccDNA serves as the 
template for transcription by host factors. The 
viral DNA genome is then synthesized in the 
lumen of the capsid by reverse transcription 
of the 3.5-kb RNA followed by second-strand 
DNA synthesis. The nucleocapsid can follow 
two different pathways. It can stay within the 
cell, in which case its genome contributes to the 
intracellular amplifi cation of the viral episomes 
(Tuttleman et al., 1986).
Leptomycin B or LMB was originally 
discovered as a potent anti-fungal antibiotic 
from Streptomyces species (Hamamoto et al., 
1983). The cellular target of LMB has been 
identified as the nuclear export receptor 
CRM-1 or exportin-1 (Nishi et al., 1994), which 
is involved in nuclear traffi cking of cellular 
RNAs or proteins containing the nuclear export 
sequence (NES) (Fornerod., 1997). LMB is shown 
to inhibit nuclear export of RNAs such as cfos 
(Brennan et al., 2000) or of the NES-containing 
proteins such as α-catenin (Giannini et al., 
2004) or inhibitor of κB-alpha (IκB-α) (Huang 
et al., 2000). LMB was also shown to inhibit 
mRNA nuclear export of cyclooxygenase-2 
(COX-2), thus down-regulating the expression 
of COX-2, an infl ammatory enzyme producing 
prostaglandins, in MDA-MB-231 cells (Jang et 
al., 2003). 
Structure of the LMB is an unsaturated, 
branched-chain fatty acid which is an important 
tool in the study of nuclear export (Figure 1). 
LMB inhibits nucleo-cytoplasmic translocation 
of molecules such as the HIV-1 Rev protein 
and Rev-dependent export of mRNA. Some 
cellular proteins such as actin, c-Abl, cyclin 
B1, p53, Iκb, MPF and PKA are also reported 
can be infl uenced by Leptomycin B (Ullman, 
et al., 1997; Wolff, et al., 1997; Fukuda, et al., 
1997).  Some research reported that LMB causes 
G1 cell cycle arrest in mammalian cells and it 
is a potent anti-tumor agent against murine 
experimental tumors (Yoshida et al., 1990; 
Komiyama et al, 1985). 
In this study, we evaluated the effect of 
nuclear export inhibitor LMB treatment on 
the intracellular localization of HBV core 
protein  into the hepatocyte cell lines. We also 
reported the quantifi cation of the distribution 
of EGFP-Core fusion protein with redundant 
core NLS as well as SV-40 NLS into cell 
compartment of Huh-7 and HepG2 cells. 
Materials and Methods
Main materials of this work consists 
of green fluorescence protein encoding 
DNA plasmid pEGF-C3 as plasmid control, 
HBV core fusion protein encoding DNA 
plasmid with redundant NLS of HBV core 
(pEGFP-Core 1, 2 and 3 NLS) and HBV 
core fusion protein encoding DNA plasmid 
with redundant NLS of SV-40 (pEGFP-Core 
2 and 3 NLS of SV-40). All plasmids have 
been prepared as described by Haryanto 
and Kann (2006) and Haryanto et al. (2007), 
HBV core protein nuclear export inhibitor 
Leptomycin B (SIGMA), transfection agent 
Tfx-20 (PROMEGA), hepatocyte cell lines 
Huh-7 and HepG2 cells, DMEM medium 
(GIBCO-BRL) and Fetal Calf Serum or FCS 
(GIBCO-BRL).
Plasmid desain for EGFP-core fusion protein 
and its variants
Plasmid pEGFP-C3 is a original plasmid 
and it used as control plasmid. Construction 
of recombinant plasmid pEGFP-Core 1, 
2, 3 NLS and pEGFP-Core 2 and 3 NLS of 
Figure 1. Structure of nuclear export inhibitor Lepto-
mycin B (LMB). 
Haryanto et al.
81
          I.J. Biotech.
SV-40 were designed by using synthetic 
oligonucleotides as described by  Haryanto 
and Kann (2006); and Haryanto et al. (2007). 
Preparation of Huh-7 and HepG2 cell lines 
Huh-7 and HepG2 cells were grown 
onto collagenized cover slips 24 h before 
transfection into 24 well plate. Then the 
cells were incubated over night at 37°C in 
incubator CO2 until 75-80% confl uent before 
transfected by recombinant plasmids. 
Transfection and  treatment of Leptomycin B
All recombinant DNA plasmid were 
transfected into Huh-7 and HepG2 cells in 24 
well plate. Each transfection reaction, which 
consists of 5 μl DNA plasmid (200 ng/μl), 
5 μl Tfx-20 and 300 μl FCS  free medium, 
was then mixed gently and incubated at 
room temperature for 5-10 min. The 24 well 
plate were took out from CO2 incubator and 
changed the 10% FCS containing medium 
with FCS free medium. The 24 well plate was 
returned to the CO2 incubator and continued 
the incubation for the appropriate length of 
time before transfection. Transfection was 
done, by replacing FCS free medium with 
the mixture of DNA/Tfx-20 reagent/FCS 
free medium 310 μl per well. The 24 well 
plate was incubated in the CO2 incubator 
at 37 °C for 1 h. During incubation the 10% 
FCS containing medium was warmed at 
37°C in the waterbath and Leptomycin B in 
fi nal concentration of 10 nM/ml was directly 
added in DMEM medium. Then the 24 well 
plate was incubated into the CO2 incubator 
at 37°C over night. 
Indirect immunostaining and confocal laser 
microscopy
Transfected Huh-7 and HepG2 cells were 
immunostained with mouse monoclonal 
antibody 414 anti NPC (1:500) as primary 
antibody and labeled with secondary 
antibody anti mouse, which marked texas red 
dye (1:100). Then the intracellular localization 
of EGFP-Core fusion protein determined 
under confocal laser microscope as described 
before by Haryanto (2006). 
Quantifi cation of intracellular localization
The HBV core fusion protein which 
found localized in the cell compartment, was 
quantified manually using confocal laser 
scanning microscope. The Amount of HBV 
core protein that distributed in the cytoplasm, 
nucleus or both of cell compartment were 
quantifi ed in the absolute and relative values.
Results and Discussion
Leptomycin B (LMB) is known as a nuclear 
export inhibitor. It works to prevent the export 
of proteins from the nucleus to the cytoplasm, 
because of its ability to interact with and impair 
the function of the nuclear export factor CRM-1 
(Kudo et al, 1999). In other study,  LMB is 
reported as a very potent inducer of the p53 
response, which does not act directly through 
Figure 2. Intracelullar localization of EGFP-Core fu-
sion protein in Huh-7 cells. The fusion protein found 
localized in the nucleus (upper row), cytoplasm middle 
row, and both nucleus and cytoplasm (lower row). The 
fusion proteins are shown As green fl uorescence and 
the nuclear pore complexes (NPC) in red.  
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Table 1. Intracellular localization of fusion protein EGFP-C3, EGFP-Core fusiuon protein and its variants in Lepto-
mycin B untreated and treated into Huh-7 cells. 
the DNA damage pathway (Lain et al, 1999). 
In this research, we study the Intracellular 
localization study of HBV core protein as 
EGFP-Core fusion protein with single, double 
and triple HBV core NLS (EGFP-Core 1, 2 and 
3 NLS) as well as with single double and triple 
SV-40 NLS (EGFP-Core 1, 2 and 3 SV-40) which 
treated using nuclear export inhibitor LMB. 
The intracellular localisation of EGFP-Core and 
its variants with HBV core and SV-40 NLS in 
Huh-7 and HepG2 cells more detail depicted 
in Figure 2. 
Quantification of the distribution of 
EGFP-Core fusion proteins into cells com-
partment with cytoplasmic and nuclear 
localization into Huh-7 cell can be seen 
more detail in Table 1.  In the control group 
without LMB treatment (Figure 2)  and the 
data in Table 1 shown below indicate that the 
intracellular localization of EGFP-Core fusion 
protein and its variants are dominantly found 
into the nucleus of Huh-7 cells. Treatment 
using LMB increased nuclear localization, be-
cause the LMB inhibit specifi cally the nuclear 
export of EGFP-Core fusion protein (Wolff 
et al., 1997). In the nucleus, LMB interferes 
with the binding of the leuice-rich Rev types 
nuclear export sequence (NES) to export 
receptor exportin or CRM 1 (Fornerod et al., 
1997; Ossareh-Nazari et al., 1997). 
Table 1 shown that treatment of LMB as 
nuclear export inhibitor in Huh-7 cells caused 
retention of EGFP-Core fusion protein into 
the nucleus. This nuclear localization increase 
in all of EGFP-Core constructions. LMB 
treatment increase the nuclear localization 
of EGFP-Core and all variants, because it is 
a potent, specifi c inhibitor of nuclear export 
protein (NES). The cellular target of LMB has 
been identifi ed as the nuclear export receptor 
CRM-1 or Exportin-1. CRM-1 is responsible 
for intracellular transport mediated by the 
nuclear export signal (Fukuda et al., 1997).  It 
shown that LMB has been an important tool 
in the elucidation of the role of CRM-1 in the 
export process. The inhibition of growth of 
fi ssion yeast and mammalian cells by LMB 
was shown to be due to the inhibitory ef-
fect of LMB on CRM-1 mediated processes 
(Yoshida et al., 1990; Nishi et al., 1994). 
In other work, the intracellular localiza-
tion of EGFP-C3 as control, EGFP-Core fusion 
protein and its variants in compartment cell 
of HepG2 cells with cytoplasmic and nuclear 
localization shown more detail in Table 2.
Table 2 shown that intracellular local-
ization of EGFP-C3 and EGFP-Core fusion 
protein and its variants in HepG2 cells are 
totally different. It shown only EGFP-C3 as 
control protein predominantly found local-
No Sample Treatment Cytoplasm Nucleus Both Total
1. pEGFP-C3 No 11% 89% 0% 100%
 Leptomycin B 5% 94% 1% 100%
2. pEGFP-Core 1 NLS No 25% 75% 0% 100%
 Leptomycin B 9% 91% 0% 100%
3. pEGFP-Core 2 NLS No 18% 82% 0% 100%
 Leptomycin B 12% 88% 0% 100%
4. pEGFP-Core 3 NLS No 9% 90% 1% 100%
 Leptomycin B 5% 94% 1% 100%
5. pEGFP-Core 2 NLS of SV40 No 23% 77% 0% 100%
 Leptomycin B 12% 88% 0% 100%
6. pEGFP-Core 3 NLS of SV-40 No 18% 82% 0% 100%
 Leptomycin B 6% 94% 0% 100%
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Tabel 2. Intracellular localization of fusion protein EGFP-C3, EGFP-Core fusion protein and its variants in Leptomycin 
B untreated and treated into HepG2 cells. 
ized into the nucleus, whereas EGFP-Core 1, 
2, 3 NLS and EGP-Core 1, 2, 3 NLS of SV-40 
fusion proteins majority found localized in 
cytoplasm. Although not signifi cantly, treat-
ment with LMB increase a number of nuclear 
localization in all EGFP-Core constructions. 
The nuclear localization in HepG2 cell is not 
so high as  in Huh-7, however treatment with 
LMB also increase the nuclear localization. It 
indicated that LMB works to inhibit CRM-1 
interaction with the NES of EGFP-Core fu-
sion protein. LMB binds covalently to the 
CRM-1 protein. As known that CRM-1 is a 
karyopherin specifi c for nuclear export (ex-
portin). This CRM-1 protein directly binds 
protein that contain a leucine-rich NES 
(Fornerod et al., 1997; Fukuda et al., 1997). In 
addition,  the export mechanism appears to 
involve CRM-1 binding to both Ran-GTP and 
nucleoporins (Floer and Blobel, 1999). 
LMB is thought to function primarily as 
an inhibitor of the export of proteins from the 
nucleus to the cytoplasm because of its ability 
to interact with and impair the function of the 
nuclear export factor CRM-1 (Kudo et al., 1999). 
Although other effects of LMB that could lead 
to a DNA damage response cannot be exclud-
ed, LMB is likely to be a very potent inducer of 
the p53 response, which does not act directly 
through the DNA damage pathway (Lain et al, 
1999). It state that both in Huh-7 and HepG2 
cells treatment of  LMB caused retention of 
EGFP-Core fusion protein and its variant into 
the nucleus so the nuclear localization tend to 
increase after treatment.  It indicated clearly 
that the cellular effects of LMB are due to inhibi-
tion of the nuclear export from nucleus to cyto-
plasm cell because of LMB binding covalently 
to the CRM-1 protein. This binding occurs in 
its conserved central region at a critical cysteine 
residue and prevents formation of the complex 
between CRM-1 and the NES of cargo proteins 
(Kudo et al., 1998; Kudo et al., 1999). 
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